New Key Statistics Module, Z-Score and F-Score
SZSE:300391 Key Ratios
Market Cap ¥ M | 1,993.41 |
Enterprise Value ¥ M | 2,840.00 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 136.01 |
Price/Sales | 6.88 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 276.00 |
EPS (TTM) ¥ | -1.92 |
Beneish M-Score | -1.76 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.55 |
EV-to-EBITDA | -3.55 |
PEG | -- |
Shares Outstanding M | 350.34 |
Net Margin (%) | -242.42 |
Operating Margin % | -21.01 |
Pre-tax Margin (%) | -305.64 |
Quick Ratio | 0.97 |
Current Ratio | 1.00 |
ROA % (ttm) | -19.94 |
ROE % (ttm) | -309.32 |
ROIC % (ttm) | -3.09 |
Dividend Yield % | -- |
Altman Z-Score | -0.76 |
SZSE:300391 Number of Guru Trades
SZSE:300391 Volume of Guru Trades
Gurus Latest Trades with SZSE:300391
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300391 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Changjiang Pharmaceutical Group Co Ltd Insider Transactions
No Available Data